行业动态 - 郑州微飒生物科技有限责任公司

药效评价Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2005作者：Richard H P Porter; Georg Jaeschke; Will Spooren; Theresa M Ballard; Bernd Büttelmann; Sabine Kolczewski; Jens-Uwe Peters; Eric Prinssen; Jürgen Wichmann; Eric Vieira; Andreas Mühlemann; Silvia Gatti; Vincent Mutel; Pari Malherbe

阅读更多 →

药效评价Signal transduction during environmental stress: InsP8 operates within highly restricted contexts.

期刊：Cellular signalling发表年份：2005作者：Kuicheon Choi; Elahe Mollapour; Stephen B Shears

阅读更多 →

药效评价Metabotropic glutamate receptor 8-expressing nerve terminals target subsets of GABAergic neurons in the hippocampus.

期刊：The Journal of neuroscience : the official journal of the Society for Neuroscience发表年份：2005作者：Francesco Ferraguti; Thomas Klausberger; Philip Cobden; Agnes Baude; J David B Roberts; Peter Szucs; Ayae Kinoshita; Ryuichi Shigemoto; Peter Somogyi; Yannis Dalezios

阅读更多 →

药效评价A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo.

期刊：Proceedings of the National Academy of Sciences of the United States of America发表年份：2005作者：Kayo Mitsukawa; Rina Yamamoto; Silvio Ofner; Joachim Nozulak; Oliver Pescott; Snezana Lukic; Natacha Stoehr; Cedric Mombereau; Rainer Kuhn; Kevin H McAllister; Herman van der Putten; John F Cryan; Peter J Flor

阅读更多 →